Key result
ETV1 inhibition reduces TASK-1 current and prolongs APD90, suppressing pacing-induced TASK-1 upregulation.
Its licence doesn't allow us to show a copy here.
Why the study?
The mechanisms controlling expression of the atrial-specific potassium channel TASK-1, which regulates action potential duration and is altered in AF, are not well understood.
Does ETV1 inhibition or knockdown reduce TASK-1 expression and prolong APD90 in atrial cells and tissue?
Does ETV1 inhibition or knockdown reduce TASK-1 expression and prolong APD90 in atrial cells and tissue?
The transcription factor ETV1 directly regulates TASK-1 expression and contributes to atrial electrical remodelling, identifying it as a potential upstream therapeutic target for atrial fibrillation.
Background Atrial fibrillation (AF), the most common sustained arrhythmia, is driven by electrical and structural remodelling, including altered ion channel expression. The atrial-specific potassium channel TASK-1 regulates action potential duration (APD) and is differentially expressed in AF and left ventricular dysfunction, but the mechanisms controlling its expression are not well understood. Objective This study examines whether the transcription factor ETV1 regulates TASK-1 and contributes to atrial electrical remodelling. Methods Atrial tissue from patients with and without AF was analysed to assess the relationship between ETV1 and TASK-1 (KCNK3) expression. In HL-1 cardiomyocyte-like cells and native fibroblasts, ETV1 activity was reduced using pharmacological inhibition or siRNA-mediated knockdown. TASK-1 expression, TASK-1 current, and APD at 90% repolarization were measured. Pacing experiments tested activity-dependent TASK-1 regulation. Direct transcriptional regulation was evaluated using ChIP-qPCR and ChIP-seq to detect ETV1 binding at the KCNK3 promoter. Results ETV1 and TASK-1 levels were positively correlated in human atrial tissue. In HL-1 cells and fibroblasts, ETV1 inhibition or knockdown decreased TASK-1 expression and current and selectively prolonged APD90. Pacing-induced upregulation of TASK-1 was prevented by ETV1 inhibition, indicating a protective effect against pro-arrhythmic remodelling. ChIP-qPCR and ChIP-seq confirmed direct ETV1 binding to the KCNK3 promoter. Conclusion ETV1 directly regulates TASK-1 expression and contributes to atrial electrical remodelling, identifying ETV1 as a potential upstream therapeutic target in AF.
No takes yet. Share an insight, caveat, or question.
Beck et al. (2026) studied Atrial fibrillation. ETV1 inhibition or knockdown vs. Control was evaluated on TASK-1 expression, TASK-1 current, and action potential duration at 90% repolarization (APD90). ETV1 inhibition or knockdown decreased TASK-1 expression and current, selectively prolonged APD90, and prevented pacing-induced upregulation of TASK-1.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: